Daniela Opriș-Belinski

Mapping and predicting mortality from systemic sclerosis

Muriel Elhaï, Christophe Meune, Marouane Boubaya et al. · Annals of the Rheumatic Diseases · 2017 · 642 citations · Full text

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial

Atul Deodhar, Désirée van der Heijde, Lianne S. Gensler et al. · The Lancet · 2019 · 208 citations

Rheumatology, Spondyloarthritis, Rheumatic Diseases +8

Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study

Atul Deodhar, Alice B. Gottlieb, Wolf‐­Henning Boehncke et al. · The Lancet · 2018 · 181 citations

Rheumatology, Medicine, Systemic Treatment +9

“To Be or Not To Be,” Ten Years After: Evidence for Mixed Connective Tissue Disease as a Distinct Entity

Susanna Cappelli, Silvia Bellando-Randone, Dušanka Martinović et al. · Seminars in Arthritis and Rheumatism · 2012 · 159 citations

Surgical Pathology, Histopathology, Pathology +6

Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial

Maarten Boers, Linda Hartman, Daniela Opriș-Belinski et al. · Annals of the Rheumatic Diseases · 2022 · 149 citations · Full text